Approval of Synthetic mRNA Product for Public Use with No Genotoxicity, Oncogenicity, or Long-Term Safety Studies By Peter A. McCullough, MD, MPH Many have approached me at large events and have expressed concerns that the vaccine manufacturers where going to use mRNA on a non-emergency basis to make new and […]
FDA Approves First Vaccine for Pregnant Women to Prevent RSV in Infants Six Months Old and Younger
Remember just a few short years ago when Americans were told that pregnant women should take as few medications as possible? On August 21, 2023, the United States Food and Drug Administration (FDA) approved an RSV (Respiratory Syncytial Virus) vaccine, Pfizer’s Abrysvo, for use in pregnant women at 32- to […]